Qiu CJ, Wu S. Depression and anxiety disorders in chronic obstructive pulmonary disease patients: Prevalence, disease impact, treatment. World J Psychiatry 2024; 14(12): 1797-1803 [DOI: 10.5498/wjp.v14.i12.1797]
Corresponding Author of This Article
Chang-Jian Qiu, MD, Doctor, Department of Psychiatry, West China Hospital, Sichuan University, No. 28 Telecom South Street, Wuhou District, Chengdu 610041, Sichuan Province, China. asd1827sci@163.com
Research Domain of This Article
Psychology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Psychiatry. Dec 19, 2024; 14(12): 1797-1803 Published online Dec 19, 2024. doi: 10.5498/wjp.v14.i12.1797
Depression and anxiety disorders in chronic obstructive pulmonary disease patients: Prevalence, disease impact, treatment
Chang-Jian Qiu, Shuang Wu
Chang-Jian Qiu, Shuang Wu, Department of Psychiatry, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Wu S wrote the main manuscript; Qiu CJ performed data collection; All authors analyzed and interpreted results, reviewed the results and approved the final version of the manuscript, and were informed of each step of manuscript processing including submission, revision, revision reminder, etc.
Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chang-Jian Qiu, MD, Doctor, Department of Psychiatry, West China Hospital, Sichuan University, No. 28 Telecom South Street, Wuhou District, Chengdu 610041, Sichuan Province, China. asd1827sci@163.com
Received: September 10, 2024 Revised: September 27, 2024 Accepted: October 25, 2024 Published online: December 19, 2024 Processing time: 77 Days and 20.7 Hours
Abstract
Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder that often co-occurs with depression and anxiety, worsening disease progression and reducing quality of life. A thorough review of the existing literature was conducted, including searches in PubMed, Embase, PsycINFO, and Cochrane Library databases up to 2024. This review encompasses a critical analysis of studies reporting on the prevalence, impact, and management of depression and anxiety in COPD patients. We found a high prevalence of psychological comorbidities in COPD patients, which were associated with worse disease outcomes, including increased exacerbations, hospitalizations, and reduced health-related quality of life. Diagnosing and managing these conditions is complex due to overlapping symptoms, necessitating a comprehensive patient care approach. While there has been progress in understanding COPD comorbidities, there is a need for more personalized and integrated treatments. This review emphasizes the need for increased awareness, tailored treatment plans, and further research for effective interventions.
Core Tip: Chronic obstructive pulmonary disease (COPD) is a global respiratory condition that affects public health. Depression and anxiety often accompany COPD, which can worsen the disease and lower patient quality of life. This narrative review examines COPD patients' depression and anxiety rates, their effects on disease progression, and current treatment options.
